Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
terminatednot_applicable

Transcranial Direct Current Stimulation (tDCS) in Chronic Neuropathy

NCT02747758
completednot_applicable

Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy

NCT02866240
completednot_applicable

Interference With Cognitive Control by Transcranial Direct Current Stimulation

NCT01903538

Clinical Trials (3)

Showing 3 of 3 trials
NCT02747758Not Applicable

Transcranial Direct Current Stimulation (tDCS) in Chronic Neuropathy

Terminated
NCT02866240Not Applicable

Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy

Completed
NCT01903538Not Applicable

Interference With Cognitive Control by Transcranial Direct Current Stimulation

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3